Is Gallium citrate ga 67 approved by the US FDA?

Drugs@FDA lists 4 application product lines for Gallium citrate ga 67, including GALLIUM CITRATE GA 67 (Prescription); GALLIUM CITRATE GA 67 (Discontinued); GALLIUM CITRATE GA 67 (Discontinued); NEOSCAN (Discontinued).

Is Gallium citrate ga 67 authorised in the United Kingdom?

The MHRA category lists of UK marketing authorisations include 1 product containing Gallium citrate ga 67, including GALLIUM (GA67) CITRATE 37 MBQ/ML SOLUTION FOR INJECTION.

Active substance

Gallium citrate ga 67

US FDA 4
UK MHRA 1

Open in the medicines table

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
GALLIUM CITRATE GA 67	2mCi/ML	injectable · injection	CURIUM	Prescription	1 Feb 1979
GALLIUM CITRATE GA 67	2mCi/ML	injectable · injection	LANTHEUS MEDCL	Discontinued	17 May 1976
GALLIUM CITRATE GA 67	1mCi/ML	injectable · injection	GE HEALTHCARE	Discontinued	16 Dec 1977
NEOSCAN	2mCi/ML	injectable · injection	GE HEALTHCARE	Discontinued	1 May 1978

UK MHRA United Kingdom — marketing authorisations

Product	Authorisation	Holder	Legal status
GALLIUM (GA67) CITRATE 37 MBQ/ML SOLUTION FOR INJECTION	PL 12288/0018	CURIUM NETHERLANDS B.V.	POM

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), MHRA category lists of UK marketing authorisations (Open Government Licence v3.0), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.